Naloxone Use Does Not Explain Dip in Overdose Deaths

Data shows drug overdose deaths fell as naloxone administrations decreased, suggesting other factors drove the change.

Updated on Oct. 21, 2026 in Substance Abuse

Naloxone Use Does Not Explain Dip in Overdose Deaths

Live Poll

Is the U.S. overdose crisis finally moving in the right direction?

New analysis suggests that the nationwide decline in drug overdose deaths, which fell from a peak of 111,000 in mid-2023 to under 71,000 by late 2025, was not driven by increased naloxone usage. Researchers found that EMS responses for nonfatal overdoses and naloxone administrations actually declined concurrently with death rates during this period.

Why it matters

Understanding why overdose deaths decreased is crucial for public health, as researchers note that the drop in naloxone administration indicates factors other than expanded reversal drug access are behind the shift. This finding helps clarify the impact of current harm reduction strategies in the United States.

A study analyzing 186 million emergency medical service activations from May 2020 through December 2025 found that naloxone administrations dropped by 21 percent alongside a 33 percent decrease in nonfatal opioid overdose responses. The exact drivers behind the mortality decline remain unknown.

The players

Brown University

An academic institution where researchers conducted the retrospective analysis of emergency medical service data.

The details

Researchers tracked 2.5 million responses for nonfatal drug overdoses, identifying that 40.5 percent involved opioids. By comparing observed EMS service counts against established trends starting in May 2023, the data shows a systemic reduction in both overdose-related calls and the use of the reversal agent naloxone. Analysts caution that traffickers may eventually shift to new chemical sources or more potent synthetic opioids in response to current supply disruptions.

May 2020 marked the start of the analyzed emergency medical service activation data.
Mid-2023 represented the peak of annual U.S. drug overdose deaths at 111,000.
May 2023 was the start of the observed decline in EMS nonfatal overdose activations.
The decline in overdose deaths slowed throughout 2025.
December 2025 served as the end of the analyzed data period.

Health Landscape

This study reframes the trajectory of the overdose crisis, which reached a record high in mid-2023 before experiencing a significant downturn. It challenges the assumption that increased naloxone deployment is the primary factor explaining the shift in national mortality figures.

While this study helps clarify macro-level trends, individuals should continue to treat naloxone as a critical, life-saving tool for responding to suspected opioid overdoses. Discuss the availability and proper use of naloxone kits with your doctor or local public health department.

The takeaway

The data confirms that national drug overdose deaths dropped significantly by the end of 2025, but this change was not driven by higher naloxone usage. Always keep naloxone available if you or someone you know is at risk, and consult a physician to discuss appropriate harm reduction strategies.